Prostate cancer is one of the most common malignant tumors in men, with its incidence rising globally, particularly in the context of an increasingly aging population, leading to a growing disease burden. From 2015 to 2025, over this decade, with the rapid development of medical ...Learn More

Gastric cancer, as a globally high-incidence malignant tumor of the digestive tract, has undergone a profound transformation in its diagnostic and treatment models over the past decade, shifting from traditional empirical medicine to precise evidence-based medicine. With ...Learn More

Breast cancer, as one of the most common malignant tumors among women worldwide, has seen its treatment concepts undergo a transformative shift over the past decade from "broad-spectrum comprehensive therapy" to "precision subtype-based therapy." DengyueMed has been deeply engaged ...Learn More

DengyueMed understands that non-small cell lung cancer (NSCLC) accounts for 80%-85% of all lung cancers and is one of the leading causes of cancer-related deaths worldwide. Over the past decade, its standard therapies have undergone a revolutionary shift from "primarily ...Learn More

Cancer is a major social, public health, and economic issue, accounting for one-quarter of global deaths related to non-communicable diseases (NCDs). According to estimates from the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO), in 2022, ...Learn More